Loading…

Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents

In the present study, a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives ( 4a-4k ) were designed and subjected to molecular docking simulation studies onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said tar...

Full description

Saved in:
Bibliographic Details
Published in:RSC advances 2016-01, Vol.6 (29), p.24797-2487
Main Authors: Iyer, Vishwanathan, , Inturi, Bharathkumar, Sairam, Venkata, Pujar, Gurubasavaraj V
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3
cites cdi_FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3
container_end_page 2487
container_issue 29
container_start_page 24797
container_title RSC advances
container_volume 6
creator Iyer, Vishwanathan

Inturi, Bharathkumar
Sairam, Venkata
Pujar, Gurubasavaraj V
description In the present study, a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives ( 4a-4k ) were designed and subjected to molecular docking simulation studies onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins. In silico ADME studies highlighted that the designed compounds are safe enough and have the potential to be considered as drug like molecules, indicating the appreciable ADME property & probable toxicity of the designed compounds. The title compounds were synthesized from (benzo[ d ]oxazol-2-yl)methanamine and evaluated for in vitro radical scavenging properties and ex vivo anticoagulant activity. The results of the ex vivo anticoagulant evaluation highlighted that the compounds exhibited a significant increase in prothrombin time and clotting time, and a minimal increase in the activated partial thromboplastin time, indicating that the compounds can be considered for promising anticoagulant therapy. The results of the radical scavenging experiments indicated that the compounds have substantial antioxidant activity. A series of 1,3,4-oxadiazoles were designed and subjected to molecular docking simulation onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins.
doi_str_mv 10.1039/c6ra01158f
format article
fullrecord <record><control><sourceid>proquest_rsc_p</sourceid><recordid>TN_cdi_rsc_primary_c6ra01158f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1800474992</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3</originalsourceid><addsrcrecordid>eNpNkM9Lw0AQhRdRsNRevAs5ihjd2Ww3m5ulWBUKgj_OYTLdrZE0qTspWP96VyvqXOYdPh6PT4hjkBcgs-KSTEAJMLZ-TwyU1CZV0hT7__KhGDG_ynhmDMrAQFw9btv-xXHNSecTOM_Oddq946LGj65xnCAn69Ctaq7bZYJtX1OHy00TU4JL1_Z8JA48NuxGP38onmfXT9PbdH5_czedzFNS1vSpRZI56BxB6coTFd6SAU0graoQi8pJWXlFldYuW5CinGCcQcStQiCfDcXprjfOeds47ss4ilwTp7huwyVYKXWui0JF9GyHUuiYg_PlOtQrDNsSZPllqpyah8m3qVmET3ZwYPrl_kxmnx1MZKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1800474992</pqid></control><display><type>article</type><title>Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents</title><source>Royal Society of Chemistry</source><creator>Iyer, Vishwanathan ; ; Inturi, Bharathkumar ; Sairam, Venkata ; Pujar, Gurubasavaraj V</creator><creatorcontrib>Iyer, Vishwanathan ; ; Inturi, Bharathkumar ; Sairam, Venkata ; Pujar, Gurubasavaraj V</creatorcontrib><description>In the present study, a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives ( 4a-4k ) were designed and subjected to molecular docking simulation studies onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins. In silico ADME studies highlighted that the designed compounds are safe enough and have the potential to be considered as drug like molecules, indicating the appreciable ADME property &amp; probable toxicity of the designed compounds. The title compounds were synthesized from (benzo[ d ]oxazol-2-yl)methanamine and evaluated for in vitro radical scavenging properties and ex vivo anticoagulant activity. The results of the ex vivo anticoagulant evaluation highlighted that the compounds exhibited a significant increase in prothrombin time and clotting time, and a minimal increase in the activated partial thromboplastin time, indicating that the compounds can be considered for promising anticoagulant therapy. The results of the radical scavenging experiments indicated that the compounds have substantial antioxidant activity. A series of 1,3,4-oxadiazoles were designed and subjected to molecular docking simulation onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins.</description><identifier>ISSN: 2046-2069</identifier><identifier>EISSN: 2046-2069</identifier><identifier>DOI: 10.1039/c6ra01158f</identifier><language>eng</language><subject>Anticoagulants ; Binding ; Derivatives ; Enzymes ; Reductases ; Scavenging ; Toxicity ; Vitamins</subject><ispartof>RSC advances, 2016-01, Vol.6 (29), p.24797-2487</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3</citedby><cites>FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Iyer, Vishwanathan</creatorcontrib><creatorcontrib>Inturi, Bharathkumar</creatorcontrib><creatorcontrib>Sairam, Venkata</creatorcontrib><creatorcontrib>Pujar, Gurubasavaraj V</creatorcontrib><title>Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents</title><title>RSC advances</title><description>In the present study, a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives ( 4a-4k ) were designed and subjected to molecular docking simulation studies onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins. In silico ADME studies highlighted that the designed compounds are safe enough and have the potential to be considered as drug like molecules, indicating the appreciable ADME property &amp; probable toxicity of the designed compounds. The title compounds were synthesized from (benzo[ d ]oxazol-2-yl)methanamine and evaluated for in vitro radical scavenging properties and ex vivo anticoagulant activity. The results of the ex vivo anticoagulant evaluation highlighted that the compounds exhibited a significant increase in prothrombin time and clotting time, and a minimal increase in the activated partial thromboplastin time, indicating that the compounds can be considered for promising anticoagulant therapy. The results of the radical scavenging experiments indicated that the compounds have substantial antioxidant activity. A series of 1,3,4-oxadiazoles were designed and subjected to molecular docking simulation onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins.</description><subject>Anticoagulants</subject><subject>Binding</subject><subject>Derivatives</subject><subject>Enzymes</subject><subject>Reductases</subject><subject>Scavenging</subject><subject>Toxicity</subject><subject>Vitamins</subject><issn>2046-2069</issn><issn>2046-2069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpNkM9Lw0AQhRdRsNRevAs5ihjd2Ww3m5ulWBUKgj_OYTLdrZE0qTspWP96VyvqXOYdPh6PT4hjkBcgs-KSTEAJMLZ-TwyU1CZV0hT7__KhGDG_ynhmDMrAQFw9btv-xXHNSecTOM_Oddq946LGj65xnCAn69Ctaq7bZYJtX1OHy00TU4JL1_Z8JA48NuxGP38onmfXT9PbdH5_czedzFNS1vSpRZI56BxB6coTFd6SAU0graoQi8pJWXlFldYuW5CinGCcQcStQiCfDcXprjfOeds47ss4ilwTp7huwyVYKXWui0JF9GyHUuiYg_PlOtQrDNsSZPllqpyah8m3qVmET3ZwYPrl_kxmnx1MZKg</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Iyer, Vishwanathan</creator><creator>Inturi, Bharathkumar</creator><creator>Sairam, Venkata</creator><creator>Pujar, Gurubasavaraj V</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope></search><sort><creationdate>20160101</creationdate><title>Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents</title><author>Iyer, Vishwanathan ; ; Inturi, Bharathkumar ; Sairam, Venkata ; Pujar, Gurubasavaraj V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anticoagulants</topic><topic>Binding</topic><topic>Derivatives</topic><topic>Enzymes</topic><topic>Reductases</topic><topic>Scavenging</topic><topic>Toxicity</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iyer, Vishwanathan</creatorcontrib><creatorcontrib>Inturi, Bharathkumar</creatorcontrib><creatorcontrib>Sairam, Venkata</creatorcontrib><creatorcontrib>Pujar, Gurubasavaraj V</creatorcontrib><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><jtitle>RSC advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iyer, Vishwanathan</au><au>Inturi, Bharathkumar</au><au>Sairam, Venkata</au><au>Pujar, Gurubasavaraj V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents</atitle><jtitle>RSC advances</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>6</volume><issue>29</issue><spage>24797</spage><epage>2487</epage><pages>24797-2487</pages><issn>2046-2069</issn><eissn>2046-2069</eissn><abstract>In the present study, a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives ( 4a-4k ) were designed and subjected to molecular docking simulation studies onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins. In silico ADME studies highlighted that the designed compounds are safe enough and have the potential to be considered as drug like molecules, indicating the appreciable ADME property &amp; probable toxicity of the designed compounds. The title compounds were synthesized from (benzo[ d ]oxazol-2-yl)methanamine and evaluated for in vitro radical scavenging properties and ex vivo anticoagulant activity. The results of the ex vivo anticoagulant evaluation highlighted that the compounds exhibited a significant increase in prothrombin time and clotting time, and a minimal increase in the activated partial thromboplastin time, indicating that the compounds can be considered for promising anticoagulant therapy. The results of the radical scavenging experiments indicated that the compounds have substantial antioxidant activity. A series of 1,3,4-oxadiazoles were designed and subjected to molecular docking simulation onto the enzymes vitamin K epoxide reductase (PDB: 3KP9 ) and factor Xa (PDB: 1NFY ) to visualize their binding affinity towards the said target proteins.</abstract><doi>10.1039/c6ra01158f</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2046-2069
ispartof RSC advances, 2016-01, Vol.6 (29), p.24797-2487
issn 2046-2069
2046-2069
language eng
recordid cdi_rsc_primary_c6ra01158f
source Royal Society of Chemistry
subjects Anticoagulants
Binding
Derivatives
Enzymes
Reductases
Scavenging
Toxicity
Vitamins
title Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A40%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_rsc_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%201,3,4-oxadiazoles%20as%20promising%20anticoagulant%20agents&rft.jtitle=RSC%20advances&rft.au=Iyer,%20Vishwanathan&rft.date=2016-01-01&rft.volume=6&rft.issue=29&rft.spage=24797&rft.epage=2487&rft.pages=24797-2487&rft.issn=2046-2069&rft.eissn=2046-2069&rft_id=info:doi/10.1039/c6ra01158f&rft_dat=%3Cproquest_rsc_p%3E1800474992%3C/proquest_rsc_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c286t-8ac07147a124bfcc9f8c614c1082baa9be00bf2cb44e3dc2c7c1531a1282a1cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1800474992&rft_id=info:pmid/&rfr_iscdi=true